Search for content, post, videos

A new Swedish cell and gene therapy company has been launched

Magnus Essand and Di Yu
Elicera Therapeutics has announced that it has completed its first share issue and secured SEK 13.2 million in financing. The company is based on research by professor Magnus Essand’s research group at Uppsala University and will focus on CAR T-cells and oncolytic viruses. “In the CAR T-ce
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.